99 related articles for article (PubMed ID: 2758241)
1. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.
Boachie-Ansah G; Sitsapesan R; Kane KA; Parratt JR
Br J Pharmacol; 1989 Jul; 97(3):801-8. PubMed ID: 2758241
[TBL] [Abstract][Full Text] [Related]
2. Modification by hypoxia, hyperkalaemia and acidosis of the cardiac electrophysiological effects of a range of antiarrhythmic drugs.
Pacini DJ; Boachie-Ansah G; Kane KA
Br J Pharmacol; 1992 Nov; 107(3):665-70. PubMed ID: 1472965
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological effects of adenosine and adenosine triphosphate on sheep Purkinje fibres under normal and simulated ischaemic conditions.
Boachie-Ansah G; Kane KA; Parratt JR
Br J Pharmacol; 1989 May; 97(1):240-6. PubMed ID: 2720309
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors.
Williams FM; Rothaul AL; Kane KA; Parratt JR
J Cardiovasc Pharmacol; 1985; 7(3):550-5. PubMed ID: 2410689
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia.
Fagbemi O; Kane KA; Leprán I; Parratt JR; Szekeres L
Br J Pharmacol; 1983 Mar; 78(3):455-60. PubMed ID: 6301599
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic, antiarrhythmic, and cardioprotective effects of N-[3,5 dichlorophenyl] 4-[4-hydroxy-2-methoxy-phenyl] piperazine carboxamidine dihydrochloride (RS-87337).
Dumez D; Patmore L; Ferrandon P; Allely M; Armstrong JM
J Cardiovasc Pharmacol; 1989 Aug; 14(2):184-93. PubMed ID: 2476590
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antiarrhythmic and electrophysiologic effects of diltiazem and its analogue siratiazem.
Guc MO; Boachie-Ansah G; Kane KA; Wadsworth RM
J Cardiovasc Pharmacol; 1993 Nov; 22(5):681-6. PubMed ID: 7506318
[TBL] [Abstract][Full Text] [Related]
8. Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat.
Winslow E; Marshall RJ; Hope FG
J Cardiovasc Pharmacol; 1987 Mar; 9(3):267-75. PubMed ID: 2437392
[TBL] [Abstract][Full Text] [Related]
9. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
Barron E; Marshall RJ; Martorana M; Winslow E
Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
[TBL] [Abstract][Full Text] [Related]
10. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.
Kane KA; Winslow E
J Cardiovasc Pharmacol; 1980; 2(2):193-203. PubMed ID: 6171686
[TBL] [Abstract][Full Text] [Related]
11. Creatine phosphate suppresses ventricular arrhythmias resulting from coronary artery ligation.
Fagbemi O; Kane KA; Parratt JR
J Cardiovasc Pharmacol; 1982; 4(1):53-8. PubMed ID: 6176800
[TBL] [Abstract][Full Text] [Related]
12. Aspects of the cardiovascular pharmacology of exaprolol.
Hughes B; Kane KA; McDonald FM; Parratt JR
J Pharm Pharmacol; 1984 Sep; 36(9):597-601. PubMed ID: 6149283
[TBL] [Abstract][Full Text] [Related]
13. Effects of diet-induced hypokalaemia on the efficacy of antiarrhythmic drugs against ventricular arrhythmias evoked by coronary artery ligation in the anaesthetised rat.
Winslow E; Marshall RJ; Campbell JK; Muir AW
J Cardiovasc Pharmacol; 1987 Mar; 9(3):257-66. PubMed ID: 2437391
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
15. The electrophysiological effects of opioid receptor-selective antagonists on sheep Purkinje fibres.
McIntosh M; Kane K; Parratt J
Eur J Pharmacol; 1992 Jan; 210(1):45-51. PubMed ID: 1318204
[TBL] [Abstract][Full Text] [Related]
16. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
Toyama J; Kodama I; Honjo H; Kamiya K
Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186
[TBL] [Abstract][Full Text] [Related]
18. Cellular electrophysiological effect of terikalant in the dog heart.
Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
[TBL] [Abstract][Full Text] [Related]
20. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
